Skip to content
★ Sign in to follow
RJ

Russel J. Lander

Executive
AIM ImmunoTech Inc.
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€19k
▼ Sales (0 ops.)
—

Latest filing published 03 Mar 2011 for AIM ImmunoTech Inc., €8,320.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7
Positive at T+90
0%
Median T+90
-2.0%

Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Mar 2011 · 5730 days ago · €8,320
    -37.5%
    Entry US$24,581.96 · Close at T+365 US$15,363.72
  • Filed 03 Feb 2011 · 5758 days ago · €345
    -34.0%
    Entry US$25,606.21 · Close at T+365 US$16,900.10

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Russel J. Lander: trading record in brief

Russel J. Lander is a declared insider of AIM ImmunoTech Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 July 2010 to 1 March 2011, the count stands at 7 filings.

On the market, this insider has only ever bought: 7 purchases, €19k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2011 to date brings 7 purchases and no sales.

A typical purchase (the median) is worth €509. After 7 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -2.0%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 3 March 2011, the filings show an open-market purchase worth €8,320 in AIM ImmunoTech Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Russel J. Lander

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    11,500 USD0SEC
    25,000 shares@ US$0.46Common StockSEC:0001511792-11-000003:0
    Canonical exit: 30 May 2011 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    11,488 USD0SEC
    25,000 shares@ US$0.4595Common StockSEC:0001511792-11-000003:1
    Canonical exit: 30 May 2011 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    447 USD0SEC
    950 shares@ US$0.47Common StockSEC:0001511792-11-000002:0
    Canonical exit: 14 Oct 2010 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    780 USD0SEC
    1,500 shares@ US$0.52Common StockSEC:0001511792-11-000002:1
    Canonical exit: 21 Oct 2010 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    520 USD0SEC
    1,000 shares@ US$0.52Common StockSEC:0001511792-11-000002:2
    Canonical exit: 21 Oct 2010 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    643 USD0SEC
    1,260 shares@ US$0.51Common StockSEC:0001511792-11-000002:3
    Canonical exit: 21 Nov 2010 (T+90)
  • ▲
    VP of Process/QualityAssuranceExecutivesAIM ImmunoTech Inc.
    100 USD0SEC
    200 shares@ US$0.50Common StockSEC:0001511792-11-000002:4
    Canonical exit: 21 Nov 2010 (T+90)

7 of 7 declarations